Mara A Schonberg1, Alicia R Jacobson2, Maria Karamourtopoulos2, Gianna M Aliberti2, Adlin Pinheiro2, Alexander K Smith3, Linnaea C Schuttner4, Elyse R Park5, Mary Beth Hamel2. 1. Division of General Medicine and Primary Care, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 1309 Beacon, Office 219, Brookline, MA, 02446, USA. mschonbe@bidmc.harvard.edu. 2. Division of General Medicine and Primary Care, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 1309 Beacon, Office 219, Brookline, MA, 02446, USA. 3. Division of Geriatrics, Department of Medicine, University of California San Francisco, 533 Parnassus Ave, San Francisco, CA, 94143, USA. 4. Health Services Research & Development, VA Puget Sound Health Care System, Department of Medicine, University of Washington, Seattle, WA. 1959 NE Pacific St, Seattle, WA, 98195, USA. 5. Department of Psychiatry, Massachusetts General Hospital, 450 Brookline Avenue, Boston, MA, 02215, USA.
Abstract
BACKGROUND: Despite guidelines recommending not to continue cancer screening for adults > 75 years old, especially those with short life expectancy, primary care providers (PCPs) feel ill-prepared to discuss stopping screening with older adults. OBJECTIVE: To develop scripts and strategies for PCPs to use to discuss stopping cancer screening with adults > 75. DESIGN: Qualitative study using semi-structured interview guides to conduct individual interviews with adults > 75 years old and focus groups and/or individual interviews with PCPs. PARTICIPANTS: Forty-five PCPs and 30 patients > 75 years old participated from six community or academic Boston-area primary care practices. APPROACH: Participants were asked their thoughts on discussions around stopping cancer screening and to provide feedback on scripts that were iteratively revised for PCPs to use when discussing stopping mammography and colorectal cancer (CRC) screening. RESULTS: Twenty-one (47%) of the 45 PCPs were community based. Nineteen (63%) of the 30 patients were female, and 13 (43%) were non-Hispanic white. PCPs reported using different approaches to discuss stopping cancer screening depending on the clinical scenario. PCPs noted it was easier to discuss stopping screening when the harms of screening clearly outweighed the benefits for a patient. In these cases, PCPs felt more comfortable being more directive. When the balance between the benefits and harms of screening was less clear, PCPs endorsed shared decision-making but found this approach more challenging because it was difficult to explain why to stop screening. While patients were generally enthusiastic about screening, they also reported not wanting to undergo tests of little value and said they would stop screening if their PCP recommended it. By the end of participant interviews, no further edits were recommended to the scripts. CONCLUSIONS: To increase PCP comfort and capability to discuss stopping cancer screening with older adults, we developed scripts and strategies that PCPs may use for discussing stopping cancer screening.
BACKGROUND: Despite guidelines recommending not to continue cancer screening for adults > 75 years old, especially those with short life expectancy, primary care providers (PCPs) feel ill-prepared to discuss stopping screening with older adults. OBJECTIVE: To develop scripts and strategies for PCPs to use to discuss stopping cancer screening with adults > 75. DESIGN: Qualitative study using semi-structured interview guides to conduct individual interviews with adults > 75 years old and focus groups and/or individual interviews with PCPs. PARTICIPANTS: Forty-five PCPs and 30 patients > 75 years old participated from six community or academic Boston-area primary care practices. APPROACH: Participants were asked their thoughts on discussions around stopping cancer screening and to provide feedback on scripts that were iteratively revised for PCPs to use when discussing stopping mammography and colorectal cancer (CRC) screening. RESULTS: Twenty-one (47%) of the 45 PCPs were community based. Nineteen (63%) of the 30 patients were female, and 13 (43%) were non-Hispanic white. PCPs reported using different approaches to discuss stopping cancer screening depending on the clinical scenario. PCPs noted it was easier to discuss stopping screening when the harms of screening clearly outweighed the benefits for a patient. In these cases, PCPs felt more comfortable being more directive. When the balance between the benefits and harms of screening was less clear, PCPs endorsed shared decision-making but found this approach more challenging because it was difficult to explain why to stop screening. While patients were generally enthusiastic about screening, they also reported not wanting to undergo tests of little value and said they would stop screening if their PCP recommended it. By the end of participant interviews, no further edits were recommended to the scripts. CONCLUSIONS: To increase PCP comfort and capability to discuss stopping cancer screening with older adults, we developed scripts and strategies that PCPs may use for discussing stopping cancer screening.
Entities:
Keywords:
cancer screening; deprescribing; older adults
Authors: Jennifer Elston Lafata; Richard F Brown; Michael P Pignone; Scott Ratliff; L Aubree Shay Journal: Med Decis Making Date: 2016-07-18 Impact factor: 2.583
Authors: Nancy L Schoenborn; Jin Huang; Orla C Sheehan; Jennifer L Wolff; David L Roth; Cynthia M Boyd Journal: J Gen Intern Med Date: 2018-11-06 Impact factor: 5.128
Authors: Andrew M D Wolf; Elizabeth T H Fontham; Timothy R Church; Christopher R Flowers; Carmen E Guerra; Samuel J LaMonte; Ruth Etzioni; Matthew T McKenna; Kevin C Oeffinger; Ya-Chen Tina Shih; Louise C Walter; Kimberly S Andrews; Otis W Brawley; Durado Brooks; Stacey A Fedewa; Deana Manassaram-Baptiste; Rebecca L Siegel; Richard C Wender; Robert A Smith Journal: CA Cancer J Clin Date: 2018-05-30 Impact factor: 508.702
Authors: Mara A Schonberg; Vicky Li; Edward R Marcantonio; Roger B Davis; Ellen P McCarthy Journal: J Am Geriatr Soc Date: 2017-02-21 Impact factor: 5.562
Authors: Amir Qaseem; Jennifer S Lin; Reem A Mustafa; Carrie A Horwitch; Timothy J Wilt; Mary Ann Forciea; Nick Fitterman; Alfonso Iorio; Devan Kansagara; Michael Maroto; Robert M McLean; Janice E Tufte; Sandeep Vijan Journal: Ann Intern Med Date: 2019-04-09 Impact factor: 25.391
Authors: Erica S Breslau; Sherri Sheinfeld Gorin; Heather M Edwards; Mara A Schonberg; Nicole Saiontz; Louise C Walter Journal: J Gen Intern Med Date: 2016-03-03 Impact factor: 5.128
Authors: Laura E Brotzman; Rachel C Shelton; Jessica D Austin; Carmen B Rodriguez; Mariangela Agovino; Nathalie Moise; Parisa Tehranifar Journal: Cancer Med Date: 2022-05-26 Impact factor: 4.711
Authors: Shivani K Jindal; Maria Karamourtopoulos; Alicia R Jacobson; Adlin Pinheiro; Alexander K Smith; Mary Beth Hamel; Mara A Schonberg Journal: J Am Geriatr Soc Date: 2022-02-28 Impact factor: 7.538
Authors: Mara A Schonberg; Maria Karamourtopoulos; Alicia R Jacobson; Gianna M Aliberti; Adlin Pinheiro; Alexander K Smith; Roger B Davis; Linnaea C Schuttner; Mary Beth Hamel Journal: Innov Aging Date: 2020-07-07
Authors: Rachel A Freedman; Christina A Minami; Eric P Winer; Monica Morrow; Alexander K Smith; Louise C Walter; Mina S Sedrak; Haley Gagnon; Adriana Perilla-Glen; Hans Wildiers; Tanya M Wildes; Stuart M Lichtman; Kah Poh Loh; Etienne G C Brain; Pamela S Ganschow; Kelly K Hunt; Deborah K Mayer; Kathryn J Ruddy; Reshma Jagsi; Nancy U Lin; Beverly Canin; Barbara K LeStage; Anna C Revette; Mara A Schonberg; Nancy L Keating Journal: JAMA Oncol Date: 2021-04-01 Impact factor: 33.006
Authors: Linnaea Schuttner; Bjarni Haraldsson; Charles Maynard; Christian D Helfrich; Ashok Reddy; Toral Parikh; Karin M Nelson; Edwin Wong Journal: JAMA Netw Open Date: 2021-10-01
Authors: Mara A Schonberg; Mary Beth Hamel; Roger B Davis; Maria Karamourtopoulos; Adlin Pinheiro; Michelle C Hayes; Christina C Wee; Christine Kistler Journal: MDM Policy Pract Date: 2022-01-21
Authors: Rachel A Freedman; Anna C Revette; Haley Gagnon; Adriana Perilla-Glen; Molly Kokoski; Saida O Hussein; Erin Leone; Nicole Hixon; Rebeka Lovato; Wendy Loeser; Nancy U Lin; Christina A Minami; Beverly Canin; Barbara LeStage; Meredith Faggen; Philip D Poorvu; Jennifer McKenna; Kathryn J Ruddy; Nancy L Keating; Mara A Schonberg Journal: Breast Cancer Res Treat Date: 2022-07-30 Impact factor: 4.624
Authors: Tamara Cadet; Adlin Pinheiro; Maria Karamourtopoulos; Alicia R Jacobson; Gianna M Aliberti; Christine E Kistler; Roger B Davis; Mara A Schonberg Journal: Cancer Date: 2021-08-10 Impact factor: 6.921